The morning session of the first meeting ofthe RSM's Forum on Maternity and the Newborn was chaired by Dr Iain Chalmers (Director, National Perinatal Epidemiology Unit, Oxford) who introduced as the first speaker Dr Ann Oakley (Deputy Director Thomas Coram Unit, London). In her paper on 'The history of ultrasonography in obstetrics', she traced the use of ultrasound from its development as a submarine detection method during the First World War, through its use in the mid-1950s as a device for the detection of abdominal tumours (many of which were found to be pregnancies), to the late 1960s when its use was extended, firstly to the measurement of fetal biparietal diameter and the diagnosis of blighted ova, and later to the routine estimation, in many hospitals, of fetal growth and maturity. She noted that all this had taken place despite the lack of controlled trials to determine the safety and efficacy of the technique, and that in addition its use encouraged the substitution of 'objective' data for the 'patient-generated' data of before, a process during which the social relationship between patient and caregiver was likely to be diminished.
In the discussion which followed concern was expressed that the combination of media-generated consumer demand and the readiness ofsome members of the medical profession to use new technological procedures before they had been properly evaluated, had resulted in the use of ultrasound for a large proportion ofpregnant women. Once ultrasound became the 'norm' its use rapidly became synonymous with good care, regardless of its actual value. Since its use was painless to the pregnant woman and indeed might appear to her to have advantages, it was less likely to be questioned than, for example, induction. The combination of all those factors put the more cautious professionals in the position of having to explain, to both their colleagues and the women in their care, why they were not using the technique.
Indications
The second speaker was Dr James Neilson (Queen Mother's Hospital, Glasgow) who examined in his paper the 'Indications for ultrasonography in obstetrics'. He felt that ultrasound was useful at amniocentesis, and to identify twins. It could also establish gestational age in early pregnancy, fetal anomalies and death. A study in his hospital of late pregnancy ultrasound screening, in which the product ofcrownrump length and trunk area was calculated, was highly effective in predicting small-for-dates babies but was unable to demonstrate any benefit in either management or outcome.
He noted that the National Institutes of Health Consensus Task Force on Ultrasound in Pregnancy and the comparable British body, the Royal College of Obstetricians and Gynaecologists working party, had come to opposite conclusions on the value of early pregnancy screening after analysis of similar data.
With regard to late pregnancy screening, four randomized controlled trials of its routine use had so far been conducted. Three had failed to show any benefit while the fourth may have shown decreased mortality but the results had yet to be reported in full.
The following discussion was for the most part critical of routine early pregnancy screening. The suggestion put forward that the 'need' for an early scan might not be apparent until late pregnancy, at which time it would be too late, was countered by drawing attention to the fact that the accuracy of ultrasound in assessing the duration of gestation had not, in general, been validated by reference to pregnancies for which the date of conception was known. It was also felt that reliance on ultrasound undermined the clinical skills that professionals already possessed and would be likely to jeopardize their acquisition by most junior doctors, a fact that had been amply illustrated during the study at Queen Charlotte's Hospital, where 30% ofclinicians were so unsure of their own judgment that they had broken the code to obtain the information provided by ultrasound for women in the control group.
Controlled trials
The next speaker, Dr Adrian Grant (Epidemiologist, National Perinatal Epidemiology Unit, Oxford), reviewed the existing 'Controlled trials of routine ultrasound in pregnancy'. The five trials he analysed were difficult to aggregate as they had differed in their inclusion criteria, outcome variables and trial reporting. He did not feel, however, that they formed 0141-0768/86/ 090554-03/$02.00/0 01986 The Royal Society of Medicine an adequate basis for deciding whether the extension ofdiagnostic ultrasound done for specific indication, to routine screening of women in early or late pregnancy, was justified.
The discussion highlighted the flaws inherent in the use of weight-for-gestational age charts, and the fact that there was no clinical evidence that action taken on the basis ofintrauterine growth retardation prediction improved the pregnancy outcome. It was also suggested that more effort should be put into encouraging women to keep a record of the dates of their menstrual periods.
Possible hazards
Dr Robin Mole (former Director of the Medical Research Council Radiobiology Unit, Harwell) then considered the 'Possible hazards of imaging and doppler ultrasound in obstetrics'. He noted that cell damage was a part of natural fetal development and that some ability for self-repair was possessed by the conceptus, embryo and fetus.
Although it was possible that the absorption of ultrasound energy in biological material might cause damage by raising the local temperature or by causing gas bubbles to form and resonate, available studies indicated that ultrasound imaging and doppler applications did not cause harm by heating where a circulation existed to dissipate heat, and that the exceeding shortness ofthe pulses ofultrasound in the pulse echo system of imaging militated against local energy absorption ever building up to a level where gas bubbles could form in the tissues of warm-blooded animals.
The stages ofpregnancy at which ultrasound scans are often recommended are at 16-18 weeks and 32-34 weeks after the last menstrual period. The most vulnerable organ then is likely to be the fetal forebrain and cerebellum respectively and possible postnatal deficits in function might be in vision or hearing, not as a result of malformation but by causing a reduction in the number of functioning neurones in those parts of the infant brain.
Negative animal experiments could not, in his opinion, offer reassurance to those who were concerned about damaging events with a low rate of occurrence such as 1 in 1000 or less. None of the animal studies had been large enough to show up rare events. (As an example, he cited the fact that the serious damage that could result from intrauterine exposure to X-rays was now known to occur at the rate of 1 in 5000. Despite the now widely acknowledged danger of intrauterine exposure to X-rays, no animal study had yet shown that X-rays in utero caused cancer. All the evidence, including the most recent, came from human experience.) When considering possible links between ultrasound and childhood cancers or defects in development in childhood, information about such levels of risk cannot be obtained until adequately designed randomized controlled trials of sufficient size and with sufficient follow up have been completed.
The greater part of the general discussion which followed was taken up with the problem of consent, and a distinction was made between consent to treatment where the care would be determined with reference to the woman's own needs, and consent to a trial where treatment was allocated randomly and the trial itself was ultimately beneficial only to future generations and not the women themselves. There was also some debate on the concept ofinformed consent in relation to ultrasound, when information as to the long-term dangers was still lacking.
Womens' view
The afternoon session was chaired by Beverley Beech (Honorary Chair of the Association for Improvements in the Maternity Services and Coordinator of Healthrights, London). She introduced as her first speaker, Nancy Stewart (a representative ofthe Association for Improvements in the Maternity Services), who presented 'Women's views of ultrasonography in obstetrics'. She maintained that although a few studies ofwomen's views ofultrasonography had suggested that such scans might improve the bonding process between mother and fetus, many women described themselves as more concerned or worried after a scan than before. She felt it was possible that some women who felt relieved after a scan were only relieved offears generated by the scan procedure itself, since no significant differences were found in anxiety levels between a post-scan group and a no-scan group. She also highlighted the growing awareness of women writing to AIMS of the problems of informed consent, and risk versus benefit, and the inherent dangers ofexcessive reliance on technology at the expense of clinical skills.
The subsequent discussion considered the inability of professionals in general to learn from experience and to ensure that new technologies were fully evaluated before they became widespread. Despite the too frequent occurrence of disasters when this was not done, as detailed in William Silverman's book Retrolental Fibroplasia -a modern parable, it was noted that the only reason professionals became aware of the hazards of administering diethylstilbestrol to pregnant women was that the vaginal cancer in their female offspring was of an unusual type.
Research strategies
The final speaker of the day was Dr Stephen Thacker (Director of the Division of Surveillance and Epidemiologic Studies, Centre for Disease Control, Atlanta), who presented some 'Research strategies for the use of imaging ultrasound as a screening tool in obstetrics'. It was his view that the results of the controlled clinical trials to assess the routine clinical use of ultrasound in obstetrics had not provided convincing evidence ofbenefit, but they had provided important data on the need for further clinical research. His paper recommended research related to the efficacy, safety and cost of the routine application of ultrasound methods in clinical obstetrics, including the psychosocial and ethical implications of these applications.
The final discussion period began with a further consideration of the problem ofmeasuring the levels of energy emitted by ultrasound machines as well as the energy absorbed by the mother and her unborn child. The speakers were also asked what size clinical trials would need to be in order to determine whether there was any connection between the use of ultrasound and an event such as sudden infant death. One of the difficulties encountered by epidemiologists who wished to establish causal connections between ultrasound and any harm that it might do, was knowing precisely what sort of 'damage' to look for in the population that was being followed. This was true for general population surveillance as well as in the follow-up studies to trials.
Another aspect that was considered was cost, both total cost to the NHS and cost effectiveness. Stuart Campbell was quoted as having calculated the cost per scan to the NHS as £11. AIMS had used his calculation to compute the cost to the NHS if every woman received one scan per pregnancy and had arrived at an annual sum of £10 million. Furthermore, Campbell's report had suggested that a routine scanning programme gave an overall abnormality prevention rate of 1 in 400, a rate identical to that of sickle cell anaemia, which Kenneth Clarke, when Minister for Health, had regarded as too low a rate for a national screening programme to be cost effective.
It was suggested that the central issue in the ultrasound debate, which the controlled trials to date had not established, was whether or not routine ultrasound did any good. Discussions on the possible harmful effects were, in a sense, of secondary importance unless some positive benefit could be established. One possible way of doing this, suggested in Dr Mole's paper and amplified by others, was that women themselves should take the initiative and elect, early in pregnancy, to be randomized either in or out of routine ultrasound. This would have the added value of automatically being a multi-centre trial.
The meeting was closed by the afternoon's chairman, who thanked both the speakers and the audience, and hoped that the information they had shared would not only be disseminated, but acted upon.
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(Accepted 7April 1986) Society news News from the President (No. 1) My first and most pleasant duty is to pay tribute to my predecessor, Sir John Walton, a man of immense energy, selfless devotion to his appointed tasks and a model by which all his successors in office will be measured. Long before he became President he was renowned throughout the profession for the diversity of his talents and for the sheer volume ofhis commitments and their punctilious fulfilment. In his office of President he has shown great flair, wisdom and steady guidance, which have been so much to the benefit of the Society. It is an unenviable task indeed to follow such a man into office. It was most appropriate that the refurbished building and the new building should have been opened by Her Majesty The Queen during his Presidency.
At the time of the last Presidential newsletter (April JRSM, p. 247) we were all anticipating with interest the Council dinner and presentation of the Society's Gold Medal to Sir Cyril Clarke FRs. The event was held on 15 April and following the presentation Sir Cyril gave the most entertaining addressan interesting and quite unique after-dinner speech. Although not billed as such, Sir Cyril is also a master showman. He held his audience entranced on the genetics of butterflies and the relationship of this interest to the prevention of Rhesus factor-induced haemolytic disease of the newborn. Two beautiful mating butterflies did their best to distract attention while they sat contentedly on Sir Cyril's shoulder, but even they could not compete for attention.
In March the Society held its third Colloquium on Complementary Therapy and was privileged to receive the first of our royal visitors in 1986, The Prince of Wales. In June, the Section of Paediatrics held a two day meeting on Paediatrics and Child Health in China and Africa. Her Royal Highness Princess Anne attended the first day of the meeting for four hours, having arrived from Canada that morning. The opening of the Society's premises on 2 July by The Queen and The Duke of Edinburgh completed a memorable six months of royal visits for the Society.
This year the Stevens Lecture for the Laity was delivered on 23 June by Sir Richard Doll on the subject of'Cancer: a Preventable Disease?' Sir Richard is known not only by the profession but by the general public throughout the world for his epidemiological work on cancer, particularly that related to smoking. The lecture attracted great interest.
On the evening of the Queen's visit the Society held the Richard T Hewitt award dinner for some 200 Fellows and their guests at the Royal College of Obstetricians and Gynaecologists. The Richard T Hewitt award is given for distinguished achievement which leads to improvement of human health and is in the gift of the Royal Society of Medicine and the Royal Society of Medicine Foundation Inc. On this occasion the award was made to Dr D A Henderson of the Johns Hopkins University for his distinguished work which contributed so much to the eradication of smallpox, a unique achievement in the control of disease.
Professor J C Goligher, Professor Donald Court, Professor N F Maclagan and Mr Harold Ridley were this year elected to the Roll ofHonorary Fellows, and 0141-0768/86/ 090556-02/$02.00/0 C198 The Royal Society of Medicine
